-
1
-
-
0042466540
-
Nephrotic syndrome in childhood
-
A. A. Eddy, and J. M. Symons, "Nephrotic syndrome in childhood, " The Lancet, vol. 362, no. 9384, pp. 629-639, 2003.
-
(2003)
The Lancet
, vol.362
, Issue.9384
, pp. 629-639
-
-
Eddy, A.A.1
Symons, J.M.2
-
2
-
-
58849160788
-
Management of steroid resistant nephrotic syndrome
-
A. Bagga, A. Gulati, S. Gulati, K. P. Mehta, and M. Vijayakumar, "Management of steroid resistant nephrotic syndrome, " Indian Pediatrics, vol. 46, no. 1, pp. 35-47, 2009.
-
(2009)
Indian Pediatrics
, vol.46
, Issue.1
, pp. 35-47
-
-
Bagga, A.1
Gulati, A.2
Gulati, S.3
Mehta, K.P.4
Vijayakumar, M.5
-
3
-
-
84906587891
-
Steroidresistant idiopathic nephrotic syndrome in children: Long-Term follow-up and risk factors for end-stage renal disease
-
A. Zagury, A. L. Oliveira, J. A. Montalvão, et al., "Steroidresistant idiopathic nephrotic syndrome in children: long-Term follow-up and risk factors for end-stage renal disease, " Jornal Brasileiro de Nefrologia, vol. 35, no. 3, pp. 191-199, 2013.
-
(2013)
Jornal Brasileiro de Nefrologia
, vol.35
, Issue.3
, pp. 191-199
-
-
Zagury, A.1
Oliveira, A.L.2
Montalvão, J.A.3
-
4
-
-
0019767056
-
Primary nephrotic syndrome in children: Clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity
-
Symposium on Pediatric Nephrology
-
Symposium on Pediatric Nephrology, "Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity, " Kidney International, vol. 20, no. 6, pp. 765-771, 1981.
-
(1981)
Kidney International
, vol.20
, Issue.6
, pp. 765-771
-
-
-
5
-
-
85021677622
-
Childhood nephrotic syndrome: Steroid sensitive, steroid resistant and beyond
-
A. A. Abeyagunawardena, "Childhood nephrotic syndrome: steroid sensitive, steroid resistant and beyond, " Sri Lanka Journal of Child Health, vol. 38, no. 4, 2009.
-
(2009)
Sri Lanka Journal of Child Health
, vol.38
, Issue.4
-
-
Abeyagunawardena, A.A.1
-
6
-
-
0141634350
-
Interventions for steroid-resistant nephrotic syndrome: A systematic review
-
D. Habashy, E. M. Hodson, and J. C. Craig, "Interventions for steroid-resistant nephrotic syndrome: a systematic review, " Pediatric Nephrology, vol. 18, no. 9, pp. 906-912, 2003.
-
(2003)
Pediatric Nephrology
, vol.18
, Issue.9
, pp. 906-912
-
-
Habashy, D.1
Hodson, E.M.2
Craig, J.C.3
-
7
-
-
47749155993
-
Cyclosporin a is superior to cyclophosphamide in children with steroid-resistant nephrotic syndrome-A randomized controlled multicentre trial by the Arbeitsgemeinschaft für Pädiatrische Nephrologie
-
C. Plank, V. Kalb, B. Hinkes, F. Hildebrandt, O. Gefeller, and W. Rascher, "Cyclosporin a is superior to cyclophosphamide in children with steroid-resistant nephrotic syndrome-A randomized controlled multicentre trial by the Arbeitsgemeinschaft für Pädiatrische Nephrologie, " Pediatric Nephrology, vol. 23, no. 9, pp. 1483-1493, 2008.
-
(2008)
Pediatric Nephrology
, vol.23
, Issue.9
, pp. 1483-1493
-
-
Plank, C.1
Kalb, V.2
Hinkes, B.3
Hildebrandt, F.4
Gefeller, O.5
Rascher, W.6
-
9
-
-
1942438028
-
Microtubules as a target for anticancer drugs
-
M. A. Jordan, and L. Wilson, "Microtubules as a target for anticancer drugs, " Nature Reviews Cancer, vol. 4, no. 4, pp. 253-265, 2004.
-
(2004)
Nature Reviews Cancer
, vol.4
, Issue.4
, pp. 253-265
-
-
Jordan, M.A.1
Wilson, L.2
-
10
-
-
17544366715
-
Localization of the vinblastine-binding site on -Tubulin
-
S. S. Rai, and J. Wolff, "Localization of the vinblastine-binding site on -Tubulin, " Journal of Biological Chemistry, vol. 271, no. 25, pp. 14707-14711, 1996.
-
(1996)
Journal of Biological Chemistry
, vol.271
, Issue.25
, pp. 14707-14711
-
-
Rai, S.S.1
Wolff, J.2
-
11
-
-
23944498904
-
Down-regulation of DNA topoisomerase II leads to prolonged cell cycle transit in G2 and early M phases and increased survival to microtubule-interacting agents
-
A. Skladanowski, M.-G. Côme, M. Sabisz, A. E. Escargueil, and A. K. Larsen, "Down-regulation of DNA topoisomerase II leads to prolonged cell cycle transit in G2 and early M phases and increased survival to microtubule-interacting agents, " Molecular Pharmacology, vol. 68, no. 3, pp. 625-634, 2005.
-
(2005)
Molecular Pharmacology
, vol.68
, Issue.3
, pp. 625-634
-
-
Skladanowski, A.1
Côme, M.-G.2
Sabisz, M.3
Escargueil, A.E.4
Larsen, A.K.5
-
12
-
-
0028069463
-
Vincristine in steroid-resistant nephrotic syndrome
-
M. P. Almeida, H. A. Almeida, and F. Coelho Rosa, "Vincristine in steroid-resistant nephrotic syndrome, " Pediatric Nephrology, vol. 8, no. 1, pp. 79-80, 1994.
-
(1994)
Pediatric Nephrology
, vol.8
, Issue.1
, pp. 79-80
-
-
Almeida, M.P.1
Almeida, H.A.2
Coelho Rosa, F.3
-
13
-
-
0031777996
-
Vincristine and focal segmental sclerosis: Do we need a multicentre trial?
-
C. D. A. Goonasekera, A. B. Koziell, S. A. Hulton, and M. J. Dillon, "Vincristine and focal segmental sclerosis: do we need a multicentre trial?" Pediatric Nephrology, vol. 12, no. 4, pp. 284-289, 1998.
-
(1998)
Pediatric Nephrology
, vol.12
, Issue.4
, pp. 284-289
-
-
Goonasekera, C.D.A.1
Koziell, A.B.2
Hulton, S.A.3
Dillon, M.J.4
-
14
-
-
26044440919
-
Vincristine treatment in steroid-dependent nephrotic syndrome
-
J. Y. Kausman, L. Yin, C. L. Jones, L. Johnstone, and H. R. Powell, "Vincristine treatment in steroid-dependent nephrotic syndrome, " Pediatric Nephrology, vol. 20, no. 10, pp. 1416-1419, 2005.
-
(2005)
Pediatric Nephrology
, vol.20
, Issue.10
, pp. 1416-1419
-
-
Kausman, J.Y.1
Yin, L.2
Jones, C.L.3
Johnstone, L.4
Powell, H.R.5
-
15
-
-
33645337915
-
Is there a role for vincristine in nephrotic syndrome?
-
R. G. Krishnan, M. G. Coulthard, and N. E. Moghal, "Is there a role for vincristine in nephrotic syndrome?" Pediatric Nephrology, vol. 21, no. 4, p. 597, 2006.
-
(2006)
Pediatric Nephrology
, vol.21
, Issue.4
, pp. 597
-
-
Krishnan, R.G.1
Coulthard, M.G.2
Moghal, N.E.3
-
16
-
-
85008214447
-
Vincristine alleviates adriamycin-induced nephropathy through stabilizing actin cytoskeleton
-
L. Yin, Y. Mao, H. Song, Y. Wang, W. Zhou, and Z. Zhang, "Vincristine alleviates adriamycin-induced nephropathy through stabilizing actin cytoskeleton, " Cell &Bioscience, vol. 7, no. 1, 2017.
-
Cell &bioscience
, vol.7
, Issue.1
, pp. 2017
-
-
Yin, L.1
Mao, Y.2
Song, H.3
Wang, Y.4
Zhou, W.5
Zhang, Z.6
-
17
-
-
77954599877
-
Inhibition of podocyte FAK protects against proteinuria and foot process effacement
-
H. Ma, A. Togawa, K. Soda, et al., "Inhibition of podocyte FAK protects against proteinuria and foot process effacement, " Journal of the American Society of Nephrology, vol. 21, no. 7, pp. 1145-1156, 2010.
-
(2010)
Journal of the American Society of Nephrology
, vol.21
, Issue.7
, pp. 1145-1156
-
-
Ma, H.1
Togawa, A.2
Soda, K.3
|